Test Price
2,800 AED✅ Home Collection Available
GHR Gene Laron Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين GHR لمتلازمة لارون بتقنية التسلسل الجيني المتقدم (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Clinical Excellence & Patient‑Centred Commitment
- ✓99.9% Diagnostic Sensitivity – ISO‑accredited NGS workflows deliver near‑perfect analytical performance for GHR gene variants.
- ✓Hospital‑Grade Home Collection – VIP mobile phlebotomy (8:00 AM–11:00 PM) with ISO‑certified cold‑chain transport ensures sample integrity from your doorstep to our Dubai central lab.
- ✓Telephonic Post‑Test Clinical Guidance – A bilingual genetic counsellor explains your results in plain language, aligning with DHA interpretive standards.
- ✓Instant Insurance Verification – WhatsApp your Emirates ID and insurance card to +971 54 548 8731 for direct billing confirmation.
يقدم هذا التحليل الجيني المتطور تشخيصًا دقيقًا لمتلازمة لارون باستخدام تقنية التسلسل الجيني المتقدم، معتمدًا على معايير دبي الصحية وأفضل الممارسات العالمية.
Overview
The GHR Gene Laron Syndrome NGS Test interrogates the entire coding region of the growth hormone receptor (GHR) gene to confirm or exclude growth hormone insensitivity (Laron syndrome) in children and adults with severe short stature and characteristic biochemical profile. يكشف التحليل عن الطفرات المسببة لمتلازمة لارون بدقة فائقة.
| Feature | Our NGS Test (GeneSol Diagnostics) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Target Region | All GHR exons + splice sites (±20 bp) via NGS with >200× mean depth | Single exon or limited amplicon Sanger, missing deep intronic variants |
| Analytical Sensitivity | 99.9% for SNVs/indels; proven on Illumina NovaSeq platform | ≥95% for targeted region; lower sensitivity for low‑level mosaicism |
| Turnaround Time | 3–4 Weeks (expedited options available) | 6–8 Weeks |
| Clinical Coverage | Detects known and novel GHR mutations linked to classical, atypical Laron syndrome | Only pre‑defined common mutations; high miss rate for private familial variants |
Physician Insight & Safety Protocol
“As a DHA‑licensed physician, I understand the profound anxiety surrounding a suspected genetic endocrine disorder. The GHR NGS test provides a definitive molecular diagnosis, but it must always be interpreted in the context of a paediatric endocrinology assessment and family history. Please do not discontinue any prescribed growth hormone therapy or other medications without a focused consultation; a negative test does not rule out all forms of short stature, and a positive result opens the door to personalized management and family planning.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011
🔴 Medication Warning
Do not discontinue prescribed medication without consulting your doctor. If you are currently on recombinant IGF‑1, growth hormone, or any endocrine therapy, maintain your regimen unless advised otherwise by your treating endocrinologist. Stopping abruptly may cause metabolic decompensation.
Exclusion Criteria & ER Red Flags
- Blood collection is not advisable if you have a documented bleeding disorder or are on high‑dose anticoagulants without physician clearance.
- Recent (within 2 weeks) blood transfusion or allogeneic stem cell infusion may interfere with germline DNA interpretation; please reschedule accordingly.
- Seek immediate medical attention (call 998 or visit nearest ER) if you develop heavy bleeding, uncontrolled pain, or signs of infection at the venipuncture site after sample collection.
Patient FAQ & Clinical Guidance
Q1: How accurate is the GHR NGS test for diagnosing Laron syndrome compared to older methods?
This NGS‑based assay achieves over 99.9% analytical sensitivity for single nucleotide variants and small insertions/deletions in the GHR gene, making it the gold standard for molecular diagnosis of Laron syndrome when paired with a typical biochemical profile.
س: ما مدى دقة اختبار NGS لجين GHR في تشخيص متلازمة لارون مقارنة بالطرق التقليدية؟
ج: تصل الحساسية التحليلية لهذا الاختبار إلى ما يزيد عن 99.9%، مما يجعله الأكثر دقة في الكشف عن الطفرات المسببة للمتلازمة.
Q2: Is home collection truly reliable for a sensitive genetic test, and how is the sample preserved?
Yes, our home phlebotomy service uses certified cold‑chain containers and a dedicated logistics fleet that maintains 2–8 °C, ensuring DNA integrity identical to in‑clinic draws; the whole blood or FTA card is processed in our ISO 9001:2015 lab within 4 hours of collection.
س: هل جمع العينة في المنزل موثوق للاختبار الجيني، وكيف تتم المحافظة على العينة؟
ج: نعم، حيث تستخدم خدمة السحب المنزلي حاويات مبردة معتمدة تحافظ على درجة حرارة بين 2-8 مئوية، وتُعالج العينة في مختبرنا المعتمد خلال 4 ساعات.
Q3: Do I need a doctor’s referral or genetic counselling before taking this test in the UAE?
In compliance with UAE Federal Decree‑Law No. 41 of 2024 and CDS Law 2026, all genetic testing for minors requires parental consent and a referral from a DHA‑licensed physician; pre‑ genetic counselling is mandatory to ensure informed decision‑making and accurate family pedigree construction.
س: هل أحتاج إلى إحالة طبية أو استشارة وراثية قبل إجراء هذا الاختبار في الإمارات؟
ج: وفقًا للقانون الاتحادي رقم 41 لعام 2024 وقانون الخدمات السريرية 2026، يلزم موافقة الوالدين وإحالة طبية للأطفال، وجلسة استشارة وراثية إلزامية قبل الفحص.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians